Philippe Lambin Email
Founder and part-time CEO @ Convert Pharmaceuticals
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Philippe Lambin Work
- Founder and part-time CEO @ (September 2018 - Present)
- Professor of Precision Medicine @ (September 2017 - Present)
- Head of The Precision Medicine Dpt. @ (September 2017 - April 2023)
- Professor in Radiation Oncology @ (September 2000 - September 2017)
- Division leader of the Research institute GROW - Division Oncology @ (January 2004 - June 2017)
- Consultant @ (October 2024 - Present)
- Consultant @ (September 2023 - Present)
- Consultant @ (November 2021 - Present)
- Consultant @ (December 2020 - Present)
- Prof @ Maastricht Universisty (January 2000 - Present)
- Founder and Member of the Advisory Board @ (January 2016 - July 2024)
- Visiting Professor @ (August 2019 - August 2019)
- Visiting Professor @ (July 2018 - August 2018)
- Member of the steering committee of the Oncological Centre of Maastricht @ Maastricht University Medical Center (January 2002 - August 2017)
- Head of the Department of Radiation Oncology azM @ (January 2000 - August 2017)
- Chairman of the Board 2000-2015 @ (January 2000 - February 2015)
- Professor in Functional imaging in Radiation Oncology, Faculty of Biomedical Technology (BMT) @ (January 2006 - January 2011)
- Visiting Professor @ (January 2010 - December 2010)
- Visiting Professor @ (January 2007 - December 2007)
- Visiting Professor, Department of Radiation Oncology @ (January 2000 - January 2006)
- Radiation Oncologist, Assistant Professor @ (January 1993 - January 1999)
- Residentship in Radiation-Oncology @ Cliniques Universitaires Saint-Luc (January 1986 - January 1990)
- Residentship in Radiation-Oncology @ (January 1986 - January 1990)
- Residentship in Medicine @ (January 1984 - January 1986)
Philippe Lambin Education
- University Hospital Gasthuisberg, Louvain
Research in molecular Radiation Biology and synthetic biology (Research in molecular Radiation Biology and synthetic biology)
1996-1999 - Paris-Sud University (Paris XI)
Doctor of Philosophy - PhD (Molecular Oncology - Radiation Biology)
1993-1997 - Gray Lab, United Kingdom
Research in Molecular Radiation Biology (Research in Molecular Radiation Biology)
1991-1992 - Université catholique de Louvain
Radiation Oncologist (Radiation Oncologist)
1991 - Institut Gustave Roussy, Villejuif, France
Research in radiobiology and molecular biology (Research in radiobiology and molecular biology)
1990-1991 - Institut Gustave Roussy
Degree in Clinical Oncology (Degree in Clinical Oncology)
1990 - Institut Gustave Roussy
Clinical Research (Clinical Research)
1989-1990 - Lycee Martin V
Secondary school (Les compagnons dépanneurs)
1973-1979 - Université catholique de Louvain
Medical Degree (Medicine)
Philippe Lambin Summary
- Philippe Lambin, is currently a Founder and part-time CEO at Convert Pharmaceuticals. Philippe Lambin brings experience from previous roles at Maastricht University. Philippe Lambin holds a 1996 - 1999 Research in molecular Radiation Biology and synthetic biology in Research in molecular Radiation Biology and synthetic biology @ University Hospital Gasthuisberg, Louvain. Philippe Lambin has 1 emails on RocketReach.
Looking for a different Philippe Lambin?
Find contact details for 700 million professionals.
Others Named Philippe Lambin
Top Convert Pharmaceuticals Employees
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co